Towards Healthcare
Nanobiotechnology Market to Surge USD 420.2 Bn by 2034

Nanobiotechnology Market Leads with Pharma Innovation

The nanobiotechnology market was valued at USD 172.81 billion in 2024 and is projected to reach USD 420.2 billion by 2034, growing at a CAGR of 9.37%. The report covers segments by material, product type, and end-user, with regional insights across North America (42%), Europe, APAC, Latin America, and MEA. It includes value chain and competitive analysis of key players such as Amcor, Schott, West Pharmaceutical, and Gerresheimer, along with supplier, manufacturer, and trade data providing a clear statistical view of global market trends.

Content

  • Last Updated: 24 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The nanobiotechnology market holds a valuation of USD 189 billion as of 2025, and will expand to USD 420.2 billion by 2034, achieving a CAGR of 9.37% between 2024 and 2034.

North America is currently leading the nanobiotechnology market share by 42% due to rising collaborations among key players to bring advancements in the field.

Some key players include Lonza, Catalent, Thermo Fisher Scientific, Evonik, etc.

Key trends include rising investment in biotechnology, expansion in developing regions, and demand for advanced therapeutics in oncology & rare diseases.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC, GOV.UK, National Cancer Institute.
Any Questions